Compare · BLLN vs ELV
BLLN vs ELV
Side-by-side comparison of BillionToOne Inc. (BLLN) and Elevance Health Inc. (ELV): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BLLN and ELV operate in Medical Specialities (Health Care), so they compete in similar markets.
- ELV is the larger of the two at $92.84B, about 18.5x BLLN ($5.02B).
- BLLN has been more active in the news (14 items in the past 4 weeks vs 10 for ELV).
- ELV has more recent analyst coverage (23 ratings vs 9 for BLLN).
- Company
- BillionToOne Inc.
- Elevance Health Inc.
- Price
- -
- -
- Market cap
- $5.02B
- $92.84B
- 1M return
- -
- +0.28%
- 1Y return
- -
- +30.85%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NASDAQ
- NYSE
- IPO
- 2025
- News (4w)
- 14
- 10
- Recent ratings
- 9
- 23
ELV
Elevance Health Inc.
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Latest BLLN
- Director Kolluri Krishna Kittu disposed of 505,925 shares and acquired 108,433 shares (SEC Form 4)
- Norwest Announces $4 Billion Global, Multi-Stage Fund
- Director Ileri Firat covered exercise/tax liability with 436 shares, decreasing direct ownership by 1% to 39,895 units (SEC Form 4) (tax liability)
- Amendment: SEC Form SCHEDULE 13D/A filed by BillionToOne Inc.
- SEC Form 4 filed by BillionToOne Inc.
- SEC Form 4 filed by BillionToOne Inc.
- Chief Technology Officer Tsao David exercised 20,000 shares at a strike of $2.80 and sold $2,184,854 worth of shares (20,000 units at $109.24) as part of a pre-agreed trading plan (SEC Form 4)
- SEC Form 10-Q filed by BillionToOne Inc.
- BillionToOne Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- BillionToOne Reports Third Quarter 2026 Results and Raises 2026 Revenue Guidance
Latest ELV
- AM Best Assigns Indicative Issue Credit Ratings to Elevance Health, Inc.’s New Shelf Registration
- Elevance Health Inc. filed SEC Form 8-K: Regulation FD Disclosure
- EVP & Chief Digital Info Ofr Lavu Ratnakar sold $572,000 worth of shares (1,300 units at $440.00), decreasing direct ownership by 8% to 14,849 units (SEC Form 4)
- SEC Form S-3ASR filed by Elevance Health Inc.
- EVP & CFO Kaye Mark sold $4,658,357 worth of shares (10,584 units at $440.13) (SEC Form 4)
- SEC Form 10-Q filed by Elevance Health Inc.
- Elevance Health Names Jeff Park President of Carelon
- SEC Form 8-K filed by Elevance Health Inc.
- Elevance Health Reports Third Quarter 2026 Results; Raises Full-Year Guidance
- The Future of Healthcare: AI-Powered, Coordinated and Proactive Care